MAPK3 and melanoma: While this effect was almost undetectable after 4 h of exposure to drug, longer incubation markedly reduced ERK1/2 activity in both ERK1/2high (DMBC12) and ERK1/2low (DMBC21, DMBC28 and DMBC29) melanoma cell lines (Fig. 2d).